Bristol-Myers Squibb buy The Goldman Sachs Group, Inc.
Start price
30.10.23
/
50%
€48.25
Target price
30.10.24
€65.03
Performance (%)
0.64%
End price
31.10.24
€48.56
Summary
This prediction ended on 31.10.24 with a price of €48.56. During the runtime of the prediction for Bristol-Myers Squibb the price only changed by 0.64%. A total of €2.20 was paid as dividends for this prediction. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Bristol-Myers Squibb | 2.446% | 2.446% | -18.750% |
| iShares Core DAX® | -0.559% | 0.738% | 14.807% |
| iShares Nasdaq 100 | -0.566% | -0.324% | 3.991% |
| iShares Nikkei 225® | 1.073% | 5.624% | 19.546% |
| iShares S&P 500 | 0.868% | 0.030% | 1.475% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Bristol-Myers Squibb diskutieren
Bristol-Myers Squibb (NYSE: BMY) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $81.00 to $69.00. They now have a "buy" rating on the stock.
Ratings data for BMY provided by MarketBeat
In the thread Trading Bristol-Myers Squibb
Die von The_Goldman_Sachs_Gr gewählte maximale Laufzeit wurde überschritten